TFC Financial Management
TYRA icon

TFC Financial Management’s Tyra Biosciences TYRA Stock Holding History

TFC Financial Management’s Portfolio TYRA Stock Details TYRA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$22 Hold
1
– – ﹤0.01% 1027
2026
Q2 		$32 Hold
1
– – ﹤0.01% 1011
2026
Q1 		$39 Buy
+1
New +$32 ﹤0.01% 967

Other funds holding TYRA

Canaan Partners XI
Canaan Partners XI Menlo Park, California $66.9M AUM 86.25% 1-Year Est. Return
Oppenheimer & Co
Oppenheimer & Co New York $9.5B AUM 27.65% 1-Year Est. Return
Tema ETFs
Tema ETFs New York $2.69B AUM 42.96% 1-Year Est. Return
Y-Intercept (HK)
Y-Intercept (HK) Hong Kong $4.52B AUM 6.6% 1-Year Est. Return
Hilton Head Capital Partners
Hilton Head Capital Partners Hilton Head Island, South Carolina $185M AUM 26.97% 1-Year Est. Return
GF Fund Management
GF Fund Management Guangzhou, China $7.72B AUM 122.96% 1-Year Est. Return
Sterling Capital Management
Sterling Capital Management Charlotte, North Carolina $4.92B AUM 24.73% 1-Year Est. Return
Nisa Investment Advisors
Nisa Investment Advisors St. Louis, Missouri $34.7B AUM 25.93% 1-Year Est. Return
Versant Capital Management
Versant Capital Management Phoenix, Arizona $1.17B AUM 28.44% 1-Year Est. Return
GAMMA Investing
GAMMA Investing Foster City, California $2.96B AUM 34.38% 1-Year Est. Return

TFC Financial Management's TYRA Position: Q3 2026 in Review

TFC Financial Management held its Tyra Biosciences (TYRA) position steady in Q3 2026 at 1 share worth $22. The position accounts for ﹤0.01% of the portfolio, ranked #1027.

TFC Financial Management first reported a position in TYRA in Q1 2026 and has held it in 3 quarters since. The position peaked at $39 in Q1 2026. 16 funds tracked by Wall St. Rank hold TYRA as of Q3 2026.

  • TFC Financial Management held 1 share of Tyra Biosciences worth $22 as of Q3 2026.
  • TFC Financial Management left its Tyra Biosciences share count unchanged in Q3 2026.
  • Tyra Biosciences made up ﹤0.01% of TFC Financial Management's portfolio in Q3 2026, its #1027 holding.
  • TFC Financial Management first reported a position in Tyra Biosciences in Q1 2026 and has held it in 3 quarters since.
  • TFC Financial Management's Tyra Biosciences position peaked at $39 in Q1 2026.
  • 16 funds tracked by Wall St. Rank held Tyra Biosciences as of Q3 2026.

Based on TFC Financial Management's 13F filing for Q3 2026, filed 26 Oct 2026.